Designing phase III or IV trials for vaccines: Choosing between individual or cluster randomised trial designs

Vaccine

Volumn 27, Issue 13, 2009, Pages 1928-1931

  Vaucher, Paul ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Clinical trials as topic; Research design; Vaccines

Indexed keywords

VACCINE;

ARTICLE; CLINICAL TRIAL; CLUSTER RANDOMIZATION; DECISION MAKING; DISEASE TRANSMISSION; DRUG EFFICACY; EVALUATION; HERD IMMUNITY; HUMAN; INDIVIDUAL RANDOMIZATION; METHODOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; RANDOMIZATION; SAMPLE SIZE;

CLINICAL TRIALS, PHASE III AS TOPIC; CLINICAL TRIALS, PHASE IV AS TOPIC; CLUSTER ANALYSIS; DISEASE TRANSMISSION, INFECTIOUS; EPIDEMIOLOGY; HUMANS; IMMUNITY, HERD; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE; VACCINES;

EID: 61349161659     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.107     Document Type: Article

References (20)

1. Anderson R.M., and May R.M. Immunisation and herd immunity. Lancet 335 8690 (March) (1990) 641-645
2. Fine P.E. Herd immunity: history, theory, practice. Epidemiol Rev 15 2 (1993) 265-302
3. Halloran M.E., Haber M., Longini Jr. I.M., and Struchiner C.J. Direct and indirect effects in vaccine efficacy and effectiveness. Am J Epidemiol 133 4 (February) (1991) 323-331
4. Farrington C.P., and Miller E. Vaccine trials. Mol Biotechnol 17 1 (January) (2001) 43-58
5. Slymen D.J., and Hovell M.F. Cluster versus individual randomization in adolescent tobacco and alcohol studies: illustrations for design decisions. Int J Epidemiol 26 4 (August) (1997) 765-771
6. Ali M., and Clemens J.D. Ecological aspects in vaccine trials. Expert Rev Vaccines 7 3 (April) (2008) 279-281
7. Emch M., Ali M., Acosta C., Yunus M., Sack D.A., and Clemens J.D. Efficacy calculation in randomized trials: global or local measures?. Health Place 13 1 (March) (2007) 238-248
8. Eldridge S., Ashby D., Bennett C., Wakelin M., and Feder G. Internal and external validity of cluster randomised trials: systematic review of recent trials. BMJ 336 7649 (April) (2008) 876-880
9. Borm G.F., Melis R.J., Teerenstra S., and Peer P.G. Pseudo cluster randomization: a treatment allocation method to minimize contamination and selection bias. Stat Med 24 23 (December) (2005) 3535-3547
10. Deen J.L., and Clemens J.D. Issues in the design and implementation of vaccine trials in less developed countries. Nat Rev Drug Discov 5 11 (November) (2006) 932-940
11. Teerenstra S., Melis R.J., Peer P.G., and Borm G.F. Pseudo cluster randomization dealt with selection bias and contamination in clinical trials. J Clin Epidemiol 59 4 (April) (2006) 381-386
12. Murphy A.W., Esterman A., and Pilotto L.S. Cluster randomized controlled trials in primary care: an introduction. Eur J Gen Pract 12 2 (2006) 70-73
13. Elley C.R., Chondros P., and Kerse N.M. Randomised trials-cluster versus individual randomisation. Primary Care Alliance for Clinical Trials (PACT) network. Aust Fam Physician 33 9 (September) (2004) 759-763
14. Struchiner C.J., and Halloran M.E. Randomization and baseline transmission in vaccine field trials. Epidemiol Infect 135 2 (February) (2007) 181-194
15. Halloran M.E., and Struchiner C.J. Study designs for dependent happenings. Epidemiology 2 5 (September) (1991) 331-338
16. Paul Y. Herd immunity and herd protection. Vaccine 22 3-4 (2004) 301-302
17. Ali M., Emch M., von Seidlein L., Yunus M., Sack D.A., Rao M., et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 366 9479 (July) (2005) 44-49
18. Hayes R.J., and Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol 28 2 (April) (1999) 319-326
19. Campbell M.K., Thomson S., Ramsay C.R., MacLennan G.S., and Grimshaw J.M. Sample size calculator for cluster randomized trials. Comput Biol Med 34 2 (March) (2004) 113-125
20. Campbell M.K., Fayers P.M., and Grimshaw J.M. Determinants of the intracluster correlation coefficient in cluster randomized trials: the case of implementation research. Clin Trials 2 2 (April) (2005) 99-107